FDA clears advanced AI model for predicting heart failure risk

“Heart failure remains a significant healthcare challenge, contributing to approximately one million hospitalizations each year,” electrophysiologist Arnaud Rosier, MD, PhD, Implicity’s CEO, said in a prepared statement. “Preventing even a portion of these would be a game-changer in cardiac care. SignalHF is an innovative and effective tool that physicians can use to assess risk of hospitalization due to heart failure earlier, enabling interventions that can lead to better outcomes and reduce hospital admissions.”

“Comprehensive heart failure management includes treatment, prevention, and personalization. Implicity’s solution is part of this approach,” added Issam Ibnouhsein, Implicity’s head of data. “Our alerts are generated in context with a patient’s medical profile to help personalize care management plans. Furthermore, 75% of the alerts preceding a patient hospitalization are sent at least 14 days in advance—offering a two-week window to adjust medications or take proactive measures.”